These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 28988771)

  • 1. EGFR Ligands Differentially Stabilize Receptor Dimers to Specify Signaling Kinetics.
    Freed DM; Bessman NJ; Kiyatkin A; Salazar-Cavazos E; Byrne PO; Moore JO; Valley CC; Ferguson KM; Leahy DJ; Lidke DS; Lemmon MA
    Cell; 2017 Oct; 171(3):683-695.e18. PubMed ID: 28988771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glioblastoma mutations alter EGFR dimer structure to prevent ligand bias.
    Hu C; Leche CA; Kiyatkin A; Yu Z; Stayrook SE; Ferguson KM; Lemmon MA
    Nature; 2022 Feb; 602(7897):518-522. PubMed ID: 35140400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epiregulin-blocking antibody inhibits epiregulin-dependent EGFR signaling.
    Iijima M; Anai M; Kodama T; Shibasaki Y
    Biochem Biophys Res Commun; 2017 Jul; 489(1):83-88. PubMed ID: 28274874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of EGF receptor ligands in TCDD-induced EGFR down-regulation and cellular proliferation.
    Campion CM; Leon Carrion S; Mamidanna G; Sutter CH; Sutter TR; Cole JA
    Chem Biol Interact; 2016 Jun; 253():38-47. PubMed ID: 27117977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGF receptor ligands: recent advances.
    Singh B; Carpenter G; Coffey RJ
    F1000Res; 2016; 5():. PubMed ID: 27635238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for extended YFP-EGFR dimers in the absence of ligand on the surface of living cells.
    Kozer N; Henderson C; Jackson JT; Nice EC; Burgess AW; Clayton AH
    Phys Biol; 2011 Dec; 8(6):066002. PubMed ID: 21946082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex relationship between ligand binding and dimerization in the epidermal growth factor receptor.
    Bessman NJ; Bagchi A; Ferguson KM; Lemmon MA
    Cell Rep; 2014 Nov; 9(4):1306-17. PubMed ID: 25453753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-independent dimer formation of epidermal growth factor receptor (EGFR) is a step separable from ligand-induced EGFR signaling.
    Yu X; Sharma KD; Takahashi T; Iwamoto R; Mekada E
    Mol Biol Cell; 2002 Jul; 13(7):2547-57. PubMed ID: 12134089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R
    Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4.
    Komurasaki T; Toyoda H; Uchida D; Morimoto S
    Oncogene; 1997 Dec; 15(23):2841-8. PubMed ID: 9419975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatial control of EGF receptor activation by reversible dimerization on living cells.
    Chung I; Akita R; Vandlen R; Toomre D; Schlessinger J; Mellman I
    Nature; 2010 Apr; 464(7289):783-7. PubMed ID: 20208517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible dimerization of EGFR revealed by single-molecule fluorescence imaging using quantum dots.
    Kawashima N; Nakayama K; Itoh K; Itoh T; Ishikawa M; Biju V
    Chemistry; 2010 Jan; 16(4):1186-92. PubMed ID: 20024999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligomerization-function relationship of EGFR on living cells detected by the coiled-coil labeling and FRET microscopy.
    Yamashita H; Yano Y; Kawano K; Matsuzaki K
    Biochim Biophys Acta; 2015 Jun; 1848(6):1359-66. PubMed ID: 25771448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative experimental/theoretical studies on the EGFR dimerization under the effect of EGF/EGF analogues binding: Highlighting the importance of EGF/EGFR interactions at site III interface.
    Mehrabi M; Mahdiuni H; Rasouli H; Mansouri K; Shahlaei M; Khodarahmi R
    Int J Biol Macromol; 2018 Aug; 115():401-417. PubMed ID: 29665393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor (EGFR) signaling in cancer.
    Normanno N; De Luca A; Bianco C; Strizzi L; Mancino M; Maiello MR; Carotenuto A; De Feo G; Caponigro F; Salomon DS
    Gene; 2006 Jan; 366(1):2-16. PubMed ID: 16377102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epiregulin (EREG) is upregulated through an IL-1β autocrine loop in Caco-2 epithelial cells with reduced CFTR function.
    Massip-Copiz M; Clauzure M; Valdivieso ÁG; Santa-Coloma TA
    J Cell Biochem; 2018 Mar; 119(3):2911-2922. PubMed ID: 29091309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-molecule analysis of epidermal growth factor binding on the surface of living cells.
    Teramura Y; Ichinose J; Takagi H; Nishida K; Yanagida T; Sako Y
    EMBO J; 2006 Sep; 25(18):4215-22. PubMed ID: 16946702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A structure-based model for ligand binding and dimerization of EGF receptors.
    Klein P; Mattoon D; Lemmon MA; Schlessinger J
    Proc Natl Acad Sci U S A; 2004 Jan; 101(4):929-34. PubMed ID: 14732694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic mutations counteract intrinsic disorder in the EGFR kinase and promote receptor dimerization.
    Shan Y; Eastwood MP; Zhang X; Kim ET; Arkhipov A; Dror RO; Jumper J; Kuriyan J; Shaw DE
    Cell; 2012 May; 149(4):860-70. PubMed ID: 22579287
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.